Latest Schedule 13G passive stakes

ADAR1 Capital Management and Daniel Schneeberger have reported a 17.5% beneficial ownership stake in Rallybio Corporation.

Linden Advisors and associated entities have filed a Schedule 13G reporting an 8.7% beneficial ownership stake in Lionheart Holdings.

Merus Global Investments, LLC has filed a Schedule 13G reporting a 5.3% beneficial ownership stake in Bleichroeder Acquisition Corp. II.

Morgan Stanley has filed an amendment indicating it no longer beneficially owns more than five percent of Terns Pharmaceuticals, Inc. common stock.

Morgan Stanley has filed an amendment indicating it no longer beneficially owns more than five percent of Terns Pharmaceuticals, Inc. common stock.

Verbena Value LP and Aaron Diamond have filed a Schedule 13G reporting a 6.21% beneficial ownership stake in Hennessy Capital Investment Corp. VII.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.3% beneficial ownership stake in Insight Enterprises, Inc.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.3% beneficial ownership stake in Insight Enterprises, Inc.

Individual investor Zhang Xin has filed a Schedule 13G reporting a 9.85% beneficial ownership stake in EUDA Health Holdings Ltd.

Versa Capital Management and associated entities have reported a zero percent beneficial ownership stake in Picard Medical, Inc.

Morgan Stanley has filed an amendment to its Schedule 13G, reporting that it no longer beneficially owns more than five percent of Apellis Pharmaceuticals common stock.

Morgan Stanley has filed an amendment to its Schedule 13G, reporting that it no longer beneficially owns more than five percent of Apellis Pharmaceuticals common stock.

MetLife Investment Management, LLC has filed a Schedule 13G reporting beneficial ownership of 100% of the Series A Mandatory Redeemable Preferred Shares of Angel Oak Financial Strategies Income Term Trust.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.1% beneficial ownership stake in Blackbaud Inc.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.1% beneficial ownership stake in Blackbaud Inc.

Global X Management Company LLC has reported a 10.16% beneficial ownership stake in Titan Machinery Inc. via a Schedule 13G filing.

Morgan Stanley has filed a Schedule 13G reporting a 10% beneficial ownership stake in Aurora Innovation, Inc. Class A common stock.

Morgan Stanley has filed a Schedule 13G reporting a 10% beneficial ownership stake in Aurora Innovation, Inc. Class A common stock.

Karpus Management, Inc. has filed a Schedule 13G reporting beneficial ownership of 11.93% of Tavia Acquisition Corp. common stock.

Karpus Management, Inc. has filed an amendment to its Schedule 13G, reporting a 0% beneficial ownership stake in SIM Acquisition Corp. I.

Karpus Management, Inc. has filed a Schedule 13G reporting an 8.54% beneficial ownership stake in Quartzsea Acquisition Corp.

Karpus Management, Inc. has filed an amended Schedule 13G, reporting a 1.82% beneficial ownership stake in Legato Merger Corp. III.

Karpus Management, Inc. reports 0% beneficial ownership in GP-Act III Acquisition Corp., indicating a full divestment of its previously held stake.

Karpus Management, Inc. has filed an amendment to its Schedule 13G, reporting a 0.05% beneficial ownership stake in Flag Ship Acquisition Corp.

Nicholas John Swenson and affiliated entities have filed a Schedule 13G reporting a 6.36% beneficial ownership stake in Park Dental Partners, Inc.

ARK Investment Management and Catherine Wood have disclosed a reduction in their beneficial ownership of 908 Devices Inc. to 4.94%.

Massachusetts Financial Services Company has reported a 6% beneficial ownership stake in QIAGEN N.V. as of May 29, 2026.

Prudential Financial, Inc. has filed a Schedule 13G reporting an 11.4% beneficial ownership stake in Cabaletta Bio, Inc.

Prudential Financial, Inc. has filed a Schedule 13G reporting an 11.4% beneficial ownership stake in Cabaletta Bio, Inc.

Investment adviser PRIMECAP Management Co. has reported a 10.46% beneficial ownership stake in American Airlines Group Inc.